These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9519293)
21. Protein gates in DNA topoisomerase II. Maxwell A Nat Struct Biol; 1996 Feb; 3(2):109-12. PubMed ID: 8564532 [No Abstract] [Full Text] [Related]
22. Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide. Wu CC; Li TK; Farh L; Lin LY; Lin TS; Yu YJ; Yen TJ; Chiang CW; Chan NL Science; 2011 Jul; 333(6041):459-62. PubMed ID: 21778401 [TBL] [Abstract][Full Text] [Related]
23. Evidence for a conformational change in the DNA gyrase-DNA complex from hydroxyl radical footprinting. Orphanides G; Maxwell A Nucleic Acids Res; 1994 May; 22(9):1567-75. PubMed ID: 8202356 [TBL] [Abstract][Full Text] [Related]
24. The mechanisms of DNA topoisomerases. Roca J Trends Biochem Sci; 1995 Apr; 20(4):156-60. PubMed ID: 7770916 [TBL] [Abstract][Full Text] [Related]
25. Topoisomerase VI senses and exploits both DNA crossings and bends to facilitate strand passage. Wendorff TJ; Berger JM Elife; 2018 Mar; 7():. PubMed ID: 29595473 [TBL] [Abstract][Full Text] [Related]
26. Locking the ATP-operated clamp of DNA gyrase: probing the mechanism of strand passage. Williams NL; Howells AJ; Maxwell A J Mol Biol; 2001 Mar; 306(5):969-84. PubMed ID: 11237612 [TBL] [Abstract][Full Text] [Related]
27. Computational analysis of the chiral action of type II DNA topoisomerases. Klenin K; Langowski J; Vologodskii A J Mol Biol; 2002 Jul; 320(2):359-67. PubMed ID: 12079392 [TBL] [Abstract][Full Text] [Related]
28. Structural insights into the gating of DNA passage by the topoisomerase II DNA-gate. Chen SF; Huang NL; Lin JH; Wu CC; Wang YR; Yu YJ; Gilson MK; Chan NL Nat Commun; 2018 Aug; 9(1):3085. PubMed ID: 30082834 [TBL] [Abstract][Full Text] [Related]
29. Structure and mechanism of action of type IA DNA topoisomerases. Bugreev DV; Nevinsky GA Biochemistry (Mosc); 2009 Dec; 74(13):1467-81. PubMed ID: 20210704 [TBL] [Abstract][Full Text] [Related]
30. Theoretical models of DNA topology simplification by type IIA DNA topoisomerases. Vologodskii A Nucleic Acids Res; 2009 Jun; 37(10):3125-33. PubMed ID: 19383879 [TBL] [Abstract][Full Text] [Related]
31. DNA transport by a type II topoisomerase: direct evidence for a two-gate mechanism. Roca J; Berger JM; Harrison SC; Wang JC Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4057-62. PubMed ID: 8633016 [TBL] [Abstract][Full Text] [Related]
32. Recovery of the poisoned topoisomerase II for DNA religation: coordinated motion of the cleavage core revealed with the microsecond atomistic simulation. Huang NL; Lin JH Nucleic Acids Res; 2015 Aug; 43(14):6772-86. PubMed ID: 26150421 [TBL] [Abstract][Full Text] [Related]
33. DNA topoisomerase II selects DNA cleavage sites based on reactivity rather than binding affinity. Mueller-Planitz F; Herschlag D Nucleic Acids Res; 2007; 35(11):3764-73. PubMed ID: 17517767 [TBL] [Abstract][Full Text] [Related]
34. Kinetic proofreading can explain the supression of supercoiling of circular DNA molecules by type-II topoisomerases. Yan J; Magnasco MO; Marko JF Phys Rev E Stat Nonlin Soft Matter Phys; 2001 Mar; 63(3 Pt 1):031909. PubMed ID: 11308680 [TBL] [Abstract][Full Text] [Related]
35. A kinetic proofreading mechanism for disentanglement of DNA by topoisomerases. Yan J; Magnasco MO; Marko JF Nature; 1999 Oct; 401(6756):932-5. PubMed ID: 10553912 [TBL] [Abstract][Full Text] [Related]
36. Analysis of eukaryotic DNA topoisomerases and topoisomerase-directed drug effects. Boege F Eur J Clin Chem Clin Biochem; 1996 Nov; 34(11):873-88. PubMed ID: 8960461 [TBL] [Abstract][Full Text] [Related]
37. Local sensing of global DNA topology: from crossover geometry to type II topoisomerase processivity. Timsit Y Nucleic Acids Res; 2011 Nov; 39(20):8665-76. PubMed ID: 21764774 [TBL] [Abstract][Full Text] [Related]
38. DNA topology: topoisomerases keep it simple. Bates AD; Maxwell A Curr Biol; 1997 Dec; 7(12):R778-81. PubMed ID: 9382831 [TBL] [Abstract][Full Text] [Related]
39. Targeting DNA through-covalent interactions of reversible binding drugs. Graves DE Methods Enzymol; 2001; 340():377-95. PubMed ID: 11494860 [No Abstract] [Full Text] [Related]
40. Local selection rules that can determine specific pathways of DNA unknotting by type II DNA topoisomerases. Burnier Y; Weber C; Flammini A; Stasiak A Nucleic Acids Res; 2007; 35(15):5223-31. PubMed ID: 17670794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]